Filing Details

Accession Number:
0001209191-19-052702
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-07 17:18:37
Reporting Period:
2019-10-04
Accepted Time:
2019-10-07 17:18:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
818033 Heron Therapeutics Inc. HRTX Pharmaceutical Preparations (2834) 942875566
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1178579 C Kevin Tang 4747 Executive Drive
Suite 510
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-04 285,714 $17.50 5,799,810 No 4 P Indirect By LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,347 Indirect As Trustee
Common Stock 6,941 Direct
Footnotes
  1. The securities are held by Tang Capital Partners, LP. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of Tang Capital Partners, LP.
  2. The securities are held by Kevin Tang as custodian for his minor children, as Trustee of the Kevin C. Tang Family Trust, and as Trustee of the Tang Advisors, LLC Profit Sharing Plan.
  3. 2,147 of these securities are held by Kevin Tang's IRA.